Mycoplasma pneumoniae e chlamydia pneumoniae nelle infezioni respiratorie dell'eta pediatrica

Translated title of the contribution: Mycoplasma pneumoniae and chlamydia pneumoniae in respiratory infections in paediatric age

S. Esposito, L. Fusetti, N. Principi

Research output: Contribution to journalArticle

Abstract

In recent years, the role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory diseases has proved to be noteworthy. The recognition of these microorganism as emergent infectious agents is the most faithful indication of the difficulties encountered until a few years ago in their diagnostic definition. Both microorganisms have proved to be responsible for upper and lower respiratory tract infections primarily among children of school age. Some data, however, seem to suggest that infections can involve fairly frequently also younger children. Both for M. pneumoniae and C. pneumoniae, aetiologic diagnosis can be obtained through the demonstration of specific antibodies production, isolation and culture of microorganisms, and through molecular biology techniques. Currently, these last test is considered the most promising for the rapid diagnosis of recent infection. Considering that in paediatric age macrolides are the only drugs of choice for the treatment of M. pneumoniae and C. pneumoniae, an essential requirement for establishing the appropriate therapeutic approach to respiratory tract infections in children is to understand the quantitative importance of these microorganisms in the different age brackets.

Original languageItalian
Pages (from-to)266-276
Number of pages11
JournalGiornale Italiano di Malattie Infettive
Volume4
Issue number5
Publication statusPublished - 1998

Fingerprint

Chlamydophila pneumoniae
Mycoplasma pneumoniae
Respiratory Tract Infections
Pediatrics
Macrolides
Infection
Antibody Formation
Molecular Biology
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Mycoplasma pneumoniae e chlamydia pneumoniae nelle infezioni respiratorie dell'eta pediatrica. / Esposito, S.; Fusetti, L.; Principi, N.

In: Giornale Italiano di Malattie Infettive, Vol. 4, No. 5, 1998, p. 266-276.

Research output: Contribution to journalArticle

@article{995a85c49ee74b83906dd864bb557d71,
title = "Mycoplasma pneumoniae e chlamydia pneumoniae nelle infezioni respiratorie dell'eta pediatrica",
abstract = "In recent years, the role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory diseases has proved to be noteworthy. The recognition of these microorganism as emergent infectious agents is the most faithful indication of the difficulties encountered until a few years ago in their diagnostic definition. Both microorganisms have proved to be responsible for upper and lower respiratory tract infections primarily among children of school age. Some data, however, seem to suggest that infections can involve fairly frequently also younger children. Both for M. pneumoniae and C. pneumoniae, aetiologic diagnosis can be obtained through the demonstration of specific antibodies production, isolation and culture of microorganisms, and through molecular biology techniques. Currently, these last test is considered the most promising for the rapid diagnosis of recent infection. Considering that in paediatric age macrolides are the only drugs of choice for the treatment of M. pneumoniae and C. pneumoniae, an essential requirement for establishing the appropriate therapeutic approach to respiratory tract infections in children is to understand the quantitative importance of these microorganisms in the different age brackets.",
keywords = "Children, Chlamydia pneumoniae, Mycoplasma pneumoniae, Respiratory infections",
author = "S. Esposito and L. Fusetti and N. Principi",
year = "1998",
language = "Italian",
volume = "4",
pages = "266--276",
journal = "Giornale Italiano di Malattie Infettive",
issn = "1126-9952",
publisher = "U T E T SpA",
number = "5",

}

TY - JOUR

T1 - Mycoplasma pneumoniae e chlamydia pneumoniae nelle infezioni respiratorie dell'eta pediatrica

AU - Esposito, S.

AU - Fusetti, L.

AU - Principi, N.

PY - 1998

Y1 - 1998

N2 - In recent years, the role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory diseases has proved to be noteworthy. The recognition of these microorganism as emergent infectious agents is the most faithful indication of the difficulties encountered until a few years ago in their diagnostic definition. Both microorganisms have proved to be responsible for upper and lower respiratory tract infections primarily among children of school age. Some data, however, seem to suggest that infections can involve fairly frequently also younger children. Both for M. pneumoniae and C. pneumoniae, aetiologic diagnosis can be obtained through the demonstration of specific antibodies production, isolation and culture of microorganisms, and through molecular biology techniques. Currently, these last test is considered the most promising for the rapid diagnosis of recent infection. Considering that in paediatric age macrolides are the only drugs of choice for the treatment of M. pneumoniae and C. pneumoniae, an essential requirement for establishing the appropriate therapeutic approach to respiratory tract infections in children is to understand the quantitative importance of these microorganisms in the different age brackets.

AB - In recent years, the role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory diseases has proved to be noteworthy. The recognition of these microorganism as emergent infectious agents is the most faithful indication of the difficulties encountered until a few years ago in their diagnostic definition. Both microorganisms have proved to be responsible for upper and lower respiratory tract infections primarily among children of school age. Some data, however, seem to suggest that infections can involve fairly frequently also younger children. Both for M. pneumoniae and C. pneumoniae, aetiologic diagnosis can be obtained through the demonstration of specific antibodies production, isolation and culture of microorganisms, and through molecular biology techniques. Currently, these last test is considered the most promising for the rapid diagnosis of recent infection. Considering that in paediatric age macrolides are the only drugs of choice for the treatment of M. pneumoniae and C. pneumoniae, an essential requirement for establishing the appropriate therapeutic approach to respiratory tract infections in children is to understand the quantitative importance of these microorganisms in the different age brackets.

KW - Children

KW - Chlamydia pneumoniae

KW - Mycoplasma pneumoniae

KW - Respiratory infections

UR - http://www.scopus.com/inward/record.url?scp=0032318993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032318993&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0032318993

VL - 4

SP - 266

EP - 276

JO - Giornale Italiano di Malattie Infettive

JF - Giornale Italiano di Malattie Infettive

SN - 1126-9952

IS - 5

ER -